Weight gain is a common and challenging issue for many women during menopause, with up to 70% experiencing increased weight and changes in fat distribution1. This weight gain is linked to hormonal shifts, particularly declining estrogen, which also raises the risk of type 2 diabetes and cardiovascular disease12. Medications like semaglutide, marketed as Ozempic and Wegovy, have gained attention for their ability to promote significant weight loss and improve metabolic health, offering new hope for menopausal women struggling with weight management345.
Wegovy and Hormonal Insulin Resistance
Menopause triggers a decline in estrogen levels, which leads to a redistribution of body fat toward the abdominal area and increased insulin resistance2. These hormonal changes complicate weight management and elevate the risk of type 2 diabetes and cardiovascular disease in postmenopausal women2. Excess weight during menopause also worsens vasomotor symptoms such as hot flashes and night sweats and can negatively impact psychological well-being, including self-esteem6.
Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist containing semaglutide, has demonstrated significant efficacy in reducing body weight—often by 15% or more—and improving cardiometabolic health374. By mimicking the natural hormone GLP-1, Wegovy enhances insulin sensitivity, reduces appetite, and slows gastric emptying, which helps curb hormonally driven insulin resistance common in menopause35. Weight loss itself may further alleviate menopausal symptoms, including vasomotor disturbances, by improving metabolic function and reducing abdominal fat96.
“Menopause is a unique time in women’s lives characterized by fat redistribution to the midsection.”
— Fatima Cody Stanford, MD, MPH, MPA, Massachusetts General Hospital10
Beyond weight loss, GLP-1 receptor agonists like semaglutide improve multiple cardiometabolic parameters, including blood pressure, lipid profiles, and inflammation, which are particularly relevant for menopausal women facing increased cardiovascular risks4118. This multifaceted benefit positions Wegovy as a promising option to address both weight gain and metabolic complications during menopause.
- Reduces abdominal fat accumulation linked to estrogen decline2
- Improves insulin sensitivity and blood sugar control85
- Lowers cardiovascular risk factors such as blood pressure and cholesterol411
- May reduce vasomotor symptoms like hot flashes and night sweats through weight loss96
- Supports psychological well-being by improving body image and self-esteem6
Wegovy as a Long-Term Treatment
Wegovy’s mechanism of action involves regulating appetite through central nervous system pathways, requiring continuous drug presence to maintain its effects378. Clinical trials and real-world data consistently show that discontinuing semaglutide often leads to weight regain, underscoring the need for long-term treatment to sustain benefits8.
“Ozempic is a long-term medication and not a fad ‘weight loss injection.’ The same applies to menopausal women.”
— Priyanka Mahali, MD10
While some anecdotal reports suggest that certain women may maintain weight loss after stopping treatment, robust evidence is lacking, especially in menopausal populations10. For many patients, including those with type 2 diabetes or obesity, ongoing use of GLP-1 receptor agonists is necessary to preserve weight loss and metabolic improvements78.
- Continuous administration is required to sustain appetite suppression and weight loss8
- Weight regain is common after stopping the medication8
- Long-term use may be needed to maintain improved insulin sensitivity and cardiovascular risk reduction74
- Monitoring for side effects and adherence is essential during prolonged treatment8
- Some women may maintain weight loss post-menopause if symptoms like hot flashes and insomnia resolve10
Is Wegovy Right for You?
Deciding whether Wegovy is appropriate requires a personalized assessment by a healthcare professional, considering medical history, reproductive factors, and comorbidities312. Semaglutide is the most widely used GLP-1 receptor agonist, but newer agents like tirzepatide may offer even greater weight loss benefits1314.
Women considering Wegovy should discuss:
- Their overall health status, including history of thyroid cancer, pancreatitis, or gallbladder disease, which are contraindications1015
- Current medications and potential interactions, especially if using hormone replacement therapy (HRT)15
- The importance of combining medication with lifestyle changes such as diet, exercise, and stress management1516
- Potential side effects, including gastrointestinal symptoms like nausea, vomiting, and constipation15
- The need for long-term commitment to therapy to maintain benefits8
“In postmenopausal women with overweight or obesity treated with semaglutide, hormone therapy use was associated with an improved weight loss response.”
— Maria D Hurtado, MD, PhD, Mayo Clinic17
Combining semaglutide with menopause hormone therapy (HT) may enhance weight loss outcomes. A retrospective study found that postmenopausal women using both semaglutide and HT experienced significantly greater weight loss than those using semaglutide alone, along with improved cardiometabolic risk markers117. HT may improve sleep quality and reduce vasomotor symptoms, which can facilitate better adherence to weight loss interventions and promote healthier lifestyle habits118.
- Requires consultation with a healthcare provider experienced in menopause and obesity management1215
- May be combined with hormone therapy for enhanced weight loss and symptom control117
- Not suitable for women with certain medical conditions, such as thyroid cancer or pancreatitis1015
- Side effects are generally manageable with medical guidance15
- Lifestyle modifications remain essential alongside medication1516
- Engage in regular cardiovascular exercise (e.g., 150 minutes per week)1516
- Incorporate strength training to preserve muscle mass and support metabolism1920
- Prioritize high-protein meals to enhance satiety and muscle maintenance15
- Manage stress to reduce cortisol-related fat accumulation15
- Improve sleep quality to regulate appetite hormones and energy balance1516
